J&J Medical Connect
DARZALEX FASPRO®

(daratumumab and hyaluronidase-fihj)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)

Patient Medical Information

+ Save link

Does DARZALEX FASPRO Contain Sorbitol?

Last Updated: 02/12/2025

summary

Here is a passage from the DARZALEX FASPRO PRESCRIBING INFORMATION and PATIENT INFORMATION which may be helpful to address your question:

  • DARZALEX FASPRO contains sorbitol.1

What are the ingredients in DARZALEX FASPRO?

  • Active ingredients: Daratumumab and hyaluronidase-fihj1
  • Inactive ingredients: L-histidine, L-histidine hydrochloride monohydrate, Lmethionine, polysorbate 20, sorbitol, and water for injection1

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and PATIENT INFORMATION for DARZALEX FASPRO.1

 

References

Show
1 DARZALEX FASPRO (daratumumab and hyaluronidase) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.; https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/DARZALEX+Faspro-pi.pdf